Bank of America
CDMO

Bank of America’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bank of America’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-246,122
Closed -$3.04M – 8695
2024
Q4 		$3.04M Sell
246,122
-76,443
-24% -$876K ﹤0.01% 4070
2024
Q3 		$3.67M Sell
322,565
-81,489
-20% -$818K ﹤0.01% 4015
2024
Q2 		$2.88M Buy
404,054
+60,198
+18% +$460K ﹤0.01% 4120
2024
Q1 		$2.3M Sell
343,856
-133,760
-28% -$920K ﹤0.01% 4330
2023
Q4 		$3.1M Buy
477,616
+138,570
+41% +$893K ﹤0.01% 3968
2023
Q3 		$3.2M Buy
339,046
+86,644
+34% +$1.04M ﹤0.01% 3813
2023
Q2 		$3.53M Sell
252,402
-183,271
-42% -$3.12M ﹤0.01% 3716
2023
Q1 		$8.17M Sell
435,673
-33,450
-7% -$549K ﹤0.01% 3031
2022
Q4 		$6.46M Buy
469,123
+176,284
+60% +$2.7M ﹤0.01% 3146
2022
Q3 		$5.6M Buy
292,839
+93,854
+47% +$1.71M ﹤0.01% 3226
2022
Q2 		$3.04M Sell
198,985
-114,328
-36% -$1.69M ﹤0.01% 3918
2022
Q1 		$6.38M Buy
313,313
+57,038
+22% +$1.16M ﹤0.01% 3354
2021
Q4 		$7.48M Buy
256,275
+67,247
+36% +$1.92M ﹤0.01% 3252
2021
Q3 		$4.08M Buy
189,028
+110,182
+140% +$2.66M ﹤0.01% 3765
2021
Q2 		$2.02M Buy
78,846
+14,918
+23% +$319K ﹤0.01% 4300
2021
Q1 		$1.17M Buy
63,928
+40,843
+177% +$679K ﹤0.01% 4705
2020
Q4 		$267K Buy
23,085
+5,849
+34% +$53.5K ﹤0.01% 5410
2020
Q3 		$131K Sell
17,236
-2,587
-13% -$19.6K ﹤0.01% 5536
2020
Q2 		$131K Sell
19,823
-2,052
-9% -$11.5K ﹤0.01% 5531
2020
Q1 		$112K Buy
21,875
+590
+3% +$3.57K ﹤0.01% 5451
2019
Q4 		$163K Sell
21,285
-4,822
-18% -$28.1K ﹤0.01% 5746
2019
Q3 		$138K Buy
26,107
+6,075
+30% +$37.7K ﹤0.01% 5885
2019
Q2 		$112K Buy
20,032
+9,014
+82% +$37.2K ﹤0.01% 5955
2019
Q1 		$47K Sell
11,018
-23,179
-68% -$94.6K ﹤0.01% 6217
2018
Q4 		$140K Buy
34,197
+21,807
+176% +$114K ﹤0.01% 5728
2018
Q3 		$85K Buy
12,390
+8,166
+193% +$48.4K ﹤0.01% 5961
2018
Q2 		$17K Sell
4,224
-9,900
-70% -$34.3K ﹤0.01% 6555
2018
Q1 		$41K Buy
14,124
+9,634
+215% +$29.8K ﹤0.01% 6114
2017
Q4 		$17K Sell
4,490
-458
-9% -$1.96K ﹤0.01% 6469
2017
Q3 		$16K Sell
4,948
-223
-4% -$837 ﹤0.01% 6376
2017
Q2 		$22K Sell
5,171
-82
-2% -$336 ﹤0.01% 6199
2017
Q1 		$24K Buy
5,253
+80
+2% +$268 ﹤0.01% 6251
2016
Q4 		$12K Buy
5,173
+852
+20% +$1.99K ﹤0.01% 6506
2016
Q3 		$13K Sell
4,321
-11,159
-72% -$30K ﹤0.01% 6301
2016
Q2 		$40K Buy
15,480
+10,991
+245% +$30.6K ﹤0.01% 5930
2016
Q1 		$13K Sell
4,489
-474
-10% -$2.54K ﹤0.01% 6304
2015
Q4 		$40K Sell
4,963
-5,053
-50% -$40.8K ﹤0.01% 6140
2015
Q3 		$72K Sell
10,016
-1,351
-12% -$11.3K ﹤0.01% 5810
2015
Q2 		$104K Buy
11,367
+1,497
+15% +$14.4K ﹤0.01% 5572
2015
Q1 		$94K Buy
9,870
+1,000
+11% +$9.63K ﹤0.01% 5342
2014
Q4 		$86K Sell
8,870
-1,102
-11% -$11.1K ﹤0.01% 5991
2014
Q3 		$95K Sell
9,972
-25,659
-72% -$287K ﹤0.01% 6050
2014
Q2 		$469K Buy
35,631
+4,610
+15% +$58.1K ﹤0.01% 4698
2014
Q1 		$413K Buy
31,021
+1,926
+7% +$25.4K ﹤0.01% 4776
2013
Q4 		$284K Sell
29,095
-268
-0.9% -$2.52K ﹤0.01% 5268
2013
Q3 		$288K Sell
29,363
-35,180
-55% -$349K ﹤0.01% 5118
2013
Q2 		$583K Buy
+64,543
New +$676K ﹤0.01% 4608

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's CDMO Position: Q1 2025 in Review

Bank of America sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 246,122 shares — an estimated $3.04M sold.

Bank of America first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $8.17M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Bank of America reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bank of America sold 246,122 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $3.04M.
  • Bank of America first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
  • Bank of America's Avid Bioservices, Inc. Common Stock position peaked at $8.17M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.